Cytomx Therapeutics Stock Price History
| CTMX Stock | USD 0.67 0 0.60% |
Below is the normalized historical share price chart for CytomX Therapeutics extending back to October 08, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of CytomX Therapeutics stands at 0.67, as last reported on the 21st of March, with the highest price reaching 0.67 and the lowest price hitting 0.67 during the day.
If you're considering investing in CytomX Stock, it is important to understand the factors that can impact its price. CytomX Therapeutics secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15 % return per unit of risk over the last 3 months. CytomX Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CytomX Therapeutics' Mean Deviation of 3.64, risk adjusted performance of (0.14), and Standard Deviation of 4.63 to double-check the risk estimate we provide.
At this time, CytomX Therapeutics' Other Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation is likely to rise to about 11 M in 2025, despite the fact that Total Stockholder Equity is likely to grow to (433.2 K). . Price Earnings Ratio is likely to rise to 2.87 in 2025, whereas Price To Sales Ratio is likely to drop 0.60 in 2025. CytomX Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of October 2015 | 200 Day MA 1.103 | 50 Day MA 0.7849 | Beta 1.043 |
CytomX |
Sharpe Ratio = -0.1521
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CTMX |
Estimated Market Risk
| 4.74 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.72 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CytomX Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CytomX Therapeutics by adding CytomX Therapeutics to a well-diversified portfolio.
Price Book 5.0363 | Enterprise Value Ebitda 3.8585 | Price Sales 0.3884 | Shares Float 74.1 M | Wall Street Target Price 4.9375 |
CytomX Therapeutics Stock Price History Chart
There are several ways to analyze CytomX Stock price data. The simplest method is using a basic CytomX candlestick price chart, which shows CytomX Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 6, 2025 | 1.14 |
| Lowest Price | March 13, 2025 | 0.59 |
CytomX Therapeutics March 21, 2025 Stock Price Synopsis
Various analyses of CytomX Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell CytomX Stock. It can be used to describe the percentage change in the price of CytomX Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of CytomX Stock.| CytomX Therapeutics Price Action Indicator | (0.01) | |
| CytomX Therapeutics Price Rate Of Daily Change | 0.99 |
CytomX Therapeutics March 21, 2025 Stock Price Analysis
CytomX Stock Price History Data
The price series of CytomX Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 0.59 with a coefficient of variation of 19.93. The prices are distributed with arithmetic mean of 0.86. The median price for the last 90 days is 0.85.| Open | High | Low | Close | Volume | ||
03/21/2025 | 0.67 | 0.67 | 0.67 | 0.67 | ||
| 03/20/2025 | 0.67 | 0.69 | 0.66 | 0.67 | 696,685 | |
| 03/19/2025 | 0.61 | 0.67 | 0.60 | 0.67 | 1,217,586 | |
| 03/18/2025 | 0.62 | 0.62 | 0.59 | 0.60 | 1,511,678 | |
| 03/17/2025 | 0.66 | 0.66 | 0.61 | 0.63 | 1,491,615 | |
| 03/14/2025 | 0.58 | 0.65 | 0.58 | 0.65 | 1,160,467 | |
| 03/13/2025 | 0.58 | 0.62 | 0.56 | 0.59 | 1,660,862 | |
| 03/12/2025 | 0.61 | 0.62 | 0.57 | 0.60 | 2,502,291 | |
| 03/11/2025 | 0.64 | 0.66 | 0.61 | 0.62 | 2,008,601 | |
| 03/10/2025 | 0.65 | 0.72 | 0.62 | 0.67 | 4,625,891 | |
| 03/07/2025 | 0.71 | 0.78 | 0.64 | 0.66 | 50,255,449 | |
| 03/06/2025 | 0.62 | 0.63 | 0.60 | 0.62 | 1,206,719 | |
| 03/05/2025 | 0.66 | 0.67 | 0.61 | 0.62 | 885,662 | |
| 03/04/2025 | 0.64 | 0.66 | 0.60 | 0.65 | 311,304 | |
| 03/03/2025 | 0.66 | 0.68 | 0.65 | 0.65 | 468,555 | |
| 02/28/2025 | 0.67 | 0.69 | 0.66 | 0.68 | 323,152 | |
| 02/27/2025 | 0.67 | 0.70 | 0.66 | 0.68 | 581,129 | |
| 02/26/2025 | 0.70 | 0.71 | 0.67 | 0.68 | 616,742 | |
| 02/25/2025 | 0.73 | 0.74 | 0.68 | 0.69 | 946,876 | |
| 02/24/2025 | 0.78 | 0.79 | 0.69 | 0.74 | 1,299,839 | |
| 02/21/2025 | 0.81 | 0.82 | 0.77 | 0.78 | 458,927 | |
| 02/20/2025 | 0.81 | 0.83 | 0.79 | 0.82 | 375,147 | |
| 02/19/2025 | 0.80 | 0.82 | 0.77 | 0.80 | 609,469 | |
| 02/18/2025 | 0.80 | 0.83 | 0.79 | 0.80 | 418,820 | |
| 02/14/2025 | 0.83 | 0.84 | 0.79 | 0.80 | 885,365 | |
| 02/13/2025 | 0.80 | 0.83 | 0.78 | 0.83 | 555,563 | |
| 02/12/2025 | 0.77 | 0.80 | 0.75 | 0.79 | 647,835 | |
| 02/11/2025 | 0.78 | 0.79 | 0.75 | 0.76 | 471,740 | |
| 02/10/2025 | 0.84 | 0.84 | 0.78 | 0.79 | 1,144,538 | |
| 02/07/2025 | 0.86 | 0.88 | 0.83 | 0.84 | 551,529 | |
| 02/06/2025 | 0.93 | 0.98 | 0.87 | 0.87 | 833,048 | |
| 02/05/2025 | 0.85 | 0.96 | 0.84 | 0.94 | 993,790 | |
| 02/04/2025 | 0.85 | 0.88 | 0.83 | 0.86 | 585,808 | |
| 02/03/2025 | 0.85 | 0.88 | 0.83 | 0.84 | 655,030 | |
| 01/31/2025 | 0.88 | 0.92 | 0.84 | 0.85 | 523,766 | |
| 01/30/2025 | 0.83 | 0.88 | 0.83 | 0.88 | 619,357 | |
| 01/29/2025 | 0.83 | 0.85 | 0.82 | 0.82 | 1,183,683 | |
| 01/28/2025 | 0.88 | 0.89 | 0.82 | 0.85 | 900,657 | |
| 01/27/2025 | 0.89 | 0.91 | 0.85 | 0.87 | 686,112 | |
| 01/24/2025 | 0.86 | 0.93 | 0.85 | 0.89 | 672,459 | |
| 01/23/2025 | 0.84 | 0.88 | 0.82 | 0.87 | 467,799 | |
| 01/22/2025 | 0.88 | 0.88 | 0.83 | 0.84 | 512,747 | |
| 01/21/2025 | 0.86 | 0.89 | 0.84 | 0.87 | 1,115,824 | |
| 01/17/2025 | 0.86 | 0.86 | 0.82 | 0.84 | 621,184 | |
| 01/16/2025 | 0.85 | 0.86 | 0.81 | 0.85 | 872,157 | |
| 01/15/2025 | 0.85 | 0.86 | 0.79 | 0.86 | 1,645,695 | |
| 01/14/2025 | 0.89 | 0.92 | 0.81 | 0.84 | 1,083,136 | |
| 01/13/2025 | 0.92 | 0.92 | 0.85 | 0.89 | 905,489 | |
| 01/10/2025 | 0.96 | 0.97 | 0.86 | 0.88 | 1,529,154 | |
| 01/08/2025 | 1.04 | 1.05 | 0.93 | 0.98 | 2,531,999 | |
| 01/07/2025 | 1.15 | 1.15 | 1.00 | 1.02 | 2,003,842 | |
| 01/06/2025 | 1.13 | 1.17 | 1.11 | 1.14 | 914,272 | |
| 01/03/2025 | 1.11 | 1.13 | 1.08 | 1.13 | 729,087 | |
| 01/02/2025 | 1.01 | 1.08 | 1.01 | 1.06 | 964,517 | |
| 12/31/2024 | 1.02 | 1.05 | 0.97 | 1.03 | 810,224 | |
| 12/30/2024 | 1.05 | 1.07 | 1.00 | 1.02 | 1,327,187 | |
| 12/27/2024 | 1.10 | 1.16 | 1.06 | 1.07 | 926,650 | |
| 12/26/2024 | 1.07 | 1.15 | 1.06 | 1.13 | 1,171,547 | |
| 12/24/2024 | 1.06 | 1.10 | 1.06 | 1.07 | 1,523,314 | |
| 12/23/2024 | 1.06 | 1.11 | 1.05 | 1.09 | 1,334,054 | |
| 12/20/2024 | 1.06 | 1.10 | 1.03 | 1.09 | 1,078,991 |
About CytomX Therapeutics Stock history
CytomX Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CytomX is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CytomX Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CytomX Therapeutics stock prices may prove useful in developing a viable investing in CytomX Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 84.7 M | 52.6 M | |
| Net Loss | -104.3 M | -109.5 M |
CytomX Therapeutics Quarterly Net Working Capital |
|
CytomX Therapeutics Stock Technical Analysis
CytomX Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
CytomX Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CytomX Therapeutics' price direction in advance. Along with the technical and fundamental analysis of CytomX Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CytomX to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.14) | |||
| Jensen Alpha | (0.60) | |||
| Total Risk Alpha | (0.37) | |||
| Treynor Ratio | (0.36) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for CytomX Stock Analysis
When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.